254PMatching-adjusted indirect treatment comparison of ribociclib and palbociclib as first-line treatments for HR+, HER2– ABC. (18th September 2017) - Forsythe, A.; Chandiwana, D.; Dolph, M.; Tremblay, G.; Monaco, M.